Warner Bros. Discovery, Inc.
Compound as GLS1 inhibitor
Last updated:
Abstract:
A compound as a GLS1 inhibitor as represented by formula (I) or a pharmaceutically acceptable salt thereof. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
13 Jun 2018
Issue date:
22 Feb 2022